Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Subarachnoid Hemorrhage Diagnosis

Subarachnoid Hemorrhage Diagnosis Letters In addition, to optimize the sensitivity and specificity for of headache less likely to be subarachnoid hemorrhage in their predicting future diabetes, the American Diabetes Association sample, resulting in an estimated sensitivity that may be higher lowered the fasting glucose cut point from 110 mg/dL to 100 than what would be expected in a routine clinic. They recom- mg/dL for the diagnosis of impaired fasting glucose in their 2003 mended use of the OSHR be restricted to patients with similar 6 1 guidelines. This criterion has been widely accepted and used. characteristics. However, this spectrum effect may also be related to lower Yufang Bi, MD, PhD reliability. Specifically, a homogeneous sample of patients would Yu Xu, PhD have less variability, and as variability decreases so does the abil- Guang Ning, MD, PhD ity to use the OSHR in different patient groups over time (ie, reliability). Although developing and restricting clinical decision Author Affiliations: Key Laboratory for Endocrine and Metabolic Diseases of rule use for patients with a narrow spectrum of disease is appeal- Ministry of Health, Rui-Jin Hospital, Shanghai, China. ing because it may lead to improved sensitivity, repeated appli- Corresponding Author: Guang Ning, MD, PhD, Rui-Jin Hospital, http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA American Medical Association

Subarachnoid Hemorrhage Diagnosis

JAMA , Volume 311 (2) – Jan 8, 2014

Loading next page...
 
/lp/american-medical-association/subarachnoid-hemorrhage-diagnosis-z7ddDYQhQB

References (12)

Publisher
American Medical Association
Copyright
Copyright 2014 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
0098-7484
eISSN
1538-3598
DOI
10.1001/jama.2013.284318
pmid
24399564
Publisher site
See Article on Publisher Site

Abstract

Letters In addition, to optimize the sensitivity and specificity for of headache less likely to be subarachnoid hemorrhage in their predicting future diabetes, the American Diabetes Association sample, resulting in an estimated sensitivity that may be higher lowered the fasting glucose cut point from 110 mg/dL to 100 than what would be expected in a routine clinic. They recom- mg/dL for the diagnosis of impaired fasting glucose in their 2003 mended use of the OSHR be restricted to patients with similar 6 1 guidelines. This criterion has been widely accepted and used. characteristics. However, this spectrum effect may also be related to lower Yufang Bi, MD, PhD reliability. Specifically, a homogeneous sample of patients would Yu Xu, PhD have less variability, and as variability decreases so does the abil- Guang Ning, MD, PhD ity to use the OSHR in different patient groups over time (ie, reliability). Although developing and restricting clinical decision Author Affiliations: Key Laboratory for Endocrine and Metabolic Diseases of rule use for patients with a narrow spectrum of disease is appeal- Ministry of Health, Rui-Jin Hospital, Shanghai, China. ing because it may lead to improved sensitivity, repeated appli- Corresponding Author: Guang Ning, MD, PhD, Rui-Jin Hospital,

Journal

JAMAAmerican Medical Association

Published: Jan 8, 2014

There are no references for this article.